Bio-Techne
TECH
#1522
Rank
$11.05 B
Marketcap
$70.33
Share price
1.31%
Change (1 day)
-4.20%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - P/B ratio

P/B ratio as of March 2024 : 5.56

According to Bio-Techne's latest financial reports the company has a price-to-book ratio of 5.56.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Bio-Techne - P/B ratio (from 2001 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-316.21-12.72%
2022-12-317.12-40.37%
2021-12-3111.949.09%
2020-12-318.0126.12%
2019-12-316.3527.49%
2018-12-314.982.4%
2017-12-314.8612.9%
2016-12-314.3110.21%
2015-12-313.91-6.45%
2014-12-314.18-10.47%
2013-12-314.6728.75%
2012-12-313.63-14.24%
2011-12-314.23-6.02%
2010-12-314.50-13.98%
2009-12-315.23-9.1%
2008-12-315.754.03%
2007-12-315.53-2.42%
2006-12-315.67-26.33%
2005-12-317.6959.03%
2004-12-314.84-17.16%
2003-12-315.8410.83%
2002-12-315.27

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
4.72-15.13%๐Ÿ‡บ๐Ÿ‡ธ USA
2.81-49.41%๐Ÿ‡บ๐Ÿ‡ธ USA
6.89 23.98%๐Ÿ‡บ๐Ÿ‡ธ USA
3.44-38.10%๐Ÿ‡บ๐Ÿ‡ธ USA
2.49-55.28%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
0.9192-83.46%๐Ÿ‡บ๐Ÿ‡ธ USA
1.14-79.57%๐Ÿ‡บ๐Ÿ‡ธ USA